Breakdown | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 62.22B | 65.80B | 63.17B | 58.58B | 47.84B |
Gross Profit | 36.04B | 38.14B | 36.05B | 32.83B | 24.70B |
EBITDA | -1.60B | 153.00M | -2.64B | -1.94B | -11.73B |
Net Income | -3.06B | -161.00M | -4.20B | -3.64B | -13.21B |
Balance Sheet | |||||
Total Assets | 44.46B | 50.61B | 54.31B | 58.84B | 69.49B |
Cash, Cash Equivalents and Short-Term Investments | 2.18B | 5.89B | 6.74B | 6.34B | 6.13B |
Total Debt | 15.40B | 19.81B | 21.96B | 22.22B | 23.92B |
Total Liabilities | 28.22B | 31.18B | 34.51B | 33.79B | 37.47B |
Stockholders Equity | 16.23B | 18.97B | 19.13B | 23.34B | 28.61B |
Cash Flow | |||||
Free Cash Flow | -2.40B | -1.06B | 356.00M | -4.34B | -4.68B |
Operating Cash Flow | -228.00M | 415.00M | 1.64B | -3.28B | -3.31B |
Investing Cash Flow | 2.02B | 1.25B | -567.00M | 5.40B | -1.43B |
Financing Cash Flow | -4.81B | -2.73B | -844.00M | -2.02B | 63.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | ¥109.45B | 11.54 | 5.34% | 8.74% | 0.57% | -4.69% | |
76 Outperform | ¥61.61B | 13.94 | 2.54% | 12.39% | -11.38% | ||
72 Outperform | ¥12.01B | 17.84 | 0.61% | 0.61% | 74.55% | ||
68 Neutral | ¥37.75B | 14.18 | 2.91% | -5.75% | 49.48% | ||
63 Neutral | $17.14B | 11.11 | -7.24% | 3.14% | 1.68% | -25.43% | |
58 Neutral | ¥18.66B | 22.88 | 1.09% | 1.73% | 108.90% | ||
50 Neutral | ¥8.09B | ― | 6.17% | -9.83% | -371.31% |
Konaka Co., Ltd. reported a decrease in net sales by 11.1% for the six months ended March 31, 2025, compared to the previous year. However, the company saw a significant increase in profit attributable to owners of the parent, which rose by 129.2%. This improvement in profitability indicates effective cost management and operational efficiency despite the decline in sales. The company also announced a dividend payment plan, reflecting a positive outlook for stakeholders.